Literature DB >> 8804358

Captopril preserves function and ultrastructure in experimental radiation nephropathy.

E P Cohen1, A Molteni, P Hill, B L Fish, W F Ward, J E Moulder, F A Carone.   

Abstract

Captopril protects rat lung from radiation-induced pneumonitis and fibrosis and preserves function and survival in experimental radiation nephropathy. This study determined the structural benefit of captopril used preventively in radiation nephropathy. Twenty-eight Wag/RijMCW rats, divided in six groups, received 0 to 17 Gray total body irradiation followed by syngeneic bone marrow transplant. Captopril 0, 62.5, 125, 250, or 500 mg/l was given in the drinking water from the time of irradiation, and the rats were killed at 20 weeks. Using light and electron microscopy, kidneys of irradiated no-drug rats showed glomerular tuft capsular adhesions and hyalinization, focal tubular necrosis, severe interstitial fibrosis, and marked thickening and hyaline degeneration of the wall of interlobular arteries and arterioles, with intimal proliferation and periadventitial edema and inflammation. Lumens of the smaller arteries were often occluded. Significant collagen deposition was present in glomeruli, interstitium, and adventitia of interlobular arteries. Marked reduction of glomerular, tubular, vascular, and interstitial damage was seen in irradiated, captopril-treated animals, with only mild focal tubular interstitial injury and fibrosis seen. alpha smooth muscle actin-positive cells, probably myofibroblasts, were enhanced in the irradiated kidneys, and this expression was reduced in a dose-related fashion by captopril. There was also reduction in the arteriolar wall thickening, luminal occlusion, and collagen deposition in captopril-treated animals. The presence of elastin was not affected by radiation or drug treatment. Blood pressure and azotemia were lower and survival was higher in irradiated drug-treated rats compared with irradiated no-drug rats. We conclude that captopril exerts significant functional and structural protection against renal radiation injury. There was notable reduction in radiation-induced fibrosis in captopril-treated animals in this model, as in experimental lung radiation injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8804358

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  19 in total

1.  Animal models for medical countermeasures to radiation exposure.

Authors:  Jacqueline P Williams; Stephen L Brown; George E Georges; Martin Hauer-Jensen; Richard P Hill; Amy K Huser; David G Kirsch; Thomas J Macvittie; Kathy A Mason; Meetha M Medhora; John E Moulder; Paul Okunieff; Mary F Otterson; Michael E Robbins; James B Smathers; William H McBride
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

Review 2.  Targeting tissue angiotensin-converting enzyme for imaging cardiopulmonary fibrosis.

Authors:  Omer Aras; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

3.  Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.

Authors:  William Small; Jennifer L James; Timothy D Moore; Dan J Fintel; Stephen T Lutz; Benjamin Movsas; Mohan Suntharalingam; Yolanda I Garces; Robert Ivker; John Moulder; Stephanie Pugh; Lawrence B Berk
Journal:  Am J Clin Oncol       Date:  2018-04       Impact factor: 2.339

4.  Short-term treatment with a SOD/catalase mimetic, EUK-207, mitigates pneumonitis and fibrosis after single-dose total-body or whole-thoracic irradiation.

Authors:  Feng Gao; Brian L Fish; Aniko Szabo; Susan R Doctrow; Lakhan Kma; Robert C Molthen; John E Moulder; Elizabeth R Jacobs; Meetha Medhora
Journal:  Radiat Res       Date:  2012-09-28       Impact factor: 2.841

5.  Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.

Authors:  Deborah E Citrin; Pataje G S Prasanna; Amanda J Walker; Michael L Freeman; Iris Eke; Mary Helen Barcellos-Hoff; Molykutty J Arankalayil; Eric P Cohen; Ruth C Wilkins; Mansoor M Ahmed; Mitchell S Anscher; Benjamin Movsas; Jeffrey C Buchsbaum; Marc S Mendonca; Thomas A Wynn; C Norman Coleman
Journal:  Radiat Res       Date:  2017-05-10       Impact factor: 2.841

6.  Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation.

Authors:  John E Moulder; Eric P Cohen; Brian L Fish
Journal:  Radiat Res       Date:  2010-10-26       Impact factor: 2.841

7.  Delayed Effects of Acute Radiation Exposure in a Murine Model of the H-ARS: Multiple-Organ Injury Consequent to <10 Gy Total Body Irradiation.

Authors:  Joseph L Unthank; Steven J Miller; Ariel K Quickery; Ethan L Ferguson; Meijing Wang; Carol H Sampson; Hui Lin Chua; Matthew R DiStasi; Hailin Feng; Alexa Fisher; Barry P Katz; P Artur Plett; George E Sandusky; Rajendran Sellamuthu; Sasidhar Vemula; Eric P Cohen; Thomas J MacVittie; Christie M Orschell
Journal:  Health Phys       Date:  2015-11       Impact factor: 1.316

Review 8.  Mitigation of radiation injuries via suppression of the renin-angiotensin system: emphasis on radiation nephropathy.

Authors:  E P Cohen; B L Fish; J E Moulder
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

9.  Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.

Authors:  John E Moulder; Eric P Cohen; Brian L Fish
Journal:  Int J Radiat Biol       Date:  2014-09       Impact factor: 2.694

10.  Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.

Authors:  Md Abdul Hye Khan; Brian Fish; Geneva Wahl; Amit Sharma; John R Falck; Mahesh P Paudyal; John E Moulder; John D Imig; Eric P Cohen
Journal:  Clin Sci (Lond)       Date:  2016-01-15       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.